225 related articles for article (PubMed ID: 12008045)
21. X-linked lymphoproliferative disease is caused by deficiency of a novel SH2 domain-containing signal transduction adaptor protein.
Schuster V; Kreth HW
Immunol Rev; 2000 Dec; 178():21-8. PubMed ID: 11213803
[TBL] [Abstract][Full Text] [Related]
22. Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative disease gene product SAP.
Sayós J; Martín M; Chen A; Simarro M; Howie D; Morra M; Engel P; Terhorst C
Blood; 2001 Jun; 97(12):3867-74. PubMed ID: 11389028
[TBL] [Abstract][Full Text] [Related]
23. SH2D1A expression in Burkitt lymphoma cells is restricted to EBV positive group I lines and is downregulated in parallel with immunoblastic transformation.
Nagy N; Maeda A; Bandobashi K; Kis LL; Nishikawa J; Trivedi P; Faggioni A; Klein G; Klein E
Int J Cancer; 2002 Aug; 100(4):433-40. PubMed ID: 12115526
[TBL] [Abstract][Full Text] [Related]
24. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene.
Coffey AJ; Brooksbank RA; Brandau O; Oohashi T; Howell GR; Bye JM; Cahn AP; Durham J; Heath P; Wray P; Pavitt R; Wilkinson J; Leversha M; Huckle E; Shaw-Smith CJ; Dunham A; Rhodes S; Schuster V; Porta G; Yin L; Serafini P; Sylla B; Zollo M; Franco B; Bolino A; Seri M; Lanyi A; Davis JR; Webster D; Harris A; Lenoir G; de St Basile G; Jones A; Behloradsky BH; Achatz H; Murken J; Fassler R; Sumegi J; Romeo G; Vaudin M; Ross MT; Meindl A; Bentley DR
Nat Genet; 1998 Oct; 20(2):129-35. PubMed ID: 9771704
[TBL] [Abstract][Full Text] [Related]
25. Signaling lymphocytic activation molecule (SLAM)/SLAM-associated protein pathway regulates human B-cell tolerance.
Menard L; Cantaert T; Chamberlain N; Tangye SG; Riminton S; Church JA; Klion A; Cunningham-Rundles C; Nichols KE; Meffre E
J Allergy Clin Immunol; 2014 Apr; 133(4):1149-61. PubMed ID: 24373350
[TBL] [Abstract][Full Text] [Related]
26. SAP couples Fyn to SLAM immune receptors.
Chan B; Lanyi A; Song HK; Griesbach J; Simarro-Grande M; Poy F; Howie D; Sumegi J; Terhorst C; Eck MJ
Nat Cell Biol; 2003 Feb; 5(2):155-60. PubMed ID: 12545174
[TBL] [Abstract][Full Text] [Related]
27. The gene defective in X-linked lymphoproliferative disease controls T cell dependent immune surveillance against Epstein-Barr virus.
Howie D; Sayos J; Terhorst C; Morra M
Curr Opin Immunol; 2000 Aug; 12(4):474-8. PubMed ID: 10899030
[TBL] [Abstract][Full Text] [Related]
28. Regulation of cellular and humoral immune responses by the SLAM and SAP families of molecules.
Ma CS; Nichols KE; Tangye SG
Annu Rev Immunol; 2007; 25():337-79. PubMed ID: 17201683
[TBL] [Abstract][Full Text] [Related]
29. Molecular dissection of 2B4 signaling: implications for signal transduction by SLAM-related receptors.
Chen R; Relouzat F; Roncagalli R; Aoukaty A; Tan R; Latour S; Veillette A
Mol Cell Biol; 2004 Jun; 24(12):5144-56. PubMed ID: 15169881
[TBL] [Abstract][Full Text] [Related]
30. SAP and SLAM expression in anti-CD3 activated lymphocytes correlates with cytotoxic activity.
Mehrle S; Frank S; Schmidt J; Schmidt-Wolf IG; Märten A
Immunol Cell Biol; 2005 Feb; 83(1):33-9. PubMed ID: 15661039
[TBL] [Abstract][Full Text] [Related]
31. A spectrum of mutations in SH2D1A that causes X-linked lymphoproliferative disease and other Epstein-Barr virus-associated illnesses.
Sumegi J; Seemayer TA; Huang D; Davis JR; Morra M; Gross TG; Yin L; Romco G; Klein E; Terhorst C; Lanyi A
Leuk Lymphoma; 2002 Jun; 43(6):1189-201. PubMed ID: 12152986
[TBL] [Abstract][Full Text] [Related]
32. Role of SLAM-associated protein in the pathogenesis of autoimmune diseases and immunological disorders.
Furukawa H; Tohma S; Kitazawa H; Komori H; Nose M; Ono M
Arch Immunol Ther Exp (Warsz); 2010 Feb; 58(1):37-44. PubMed ID: 20049647
[TBL] [Abstract][Full Text] [Related]
33. Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2D1A.
Li SC; Gish G; Yang D; Coffey AJ; Forman-Kay JD; Ernberg I; Kay LE; Pawson T
Curr Biol; 1999 Dec; 9(23):1355-62. PubMed ID: 10607564
[TBL] [Abstract][Full Text] [Related]
34. Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency.
Snow AL; Marsh RA; Krummey SM; Roehrs P; Young LR; Zhang K; van Hoff J; Dhar D; Nichols KE; Filipovich AH; Su HC; Bleesing JJ; Lenardo MJ
J Clin Invest; 2009 Oct; 119(10):2976-89. PubMed ID: 19759517
[TBL] [Abstract][Full Text] [Related]
35. 2B4: an NK cell activating receptor with unique specificity and signal transduction mechanism.
Nakajima H; Colonna M
Hum Immunol; 2000 Jan; 61(1):39-43. PubMed ID: 10658976
[TBL] [Abstract][Full Text] [Related]
36. Wild-type p53 activates SAP expression in lymphoid cells.
Nagy N; Takahara M; Nishikawa J; Bourdon JC; Kis LL; Klein G; Klein E
Oncogene; 2004 Nov; 23(53):8563-70. PubMed ID: 15378026
[TBL] [Abstract][Full Text] [Related]
37. SH2D1A expression reflects activation of T and NK cells in cord blood lymphocytes infected with EBV and treated with the immunomodulator PSK.
Liu A; Klein G; Bandobashi K; Klein E; Nagy N
Immunol Lett; 2002 Mar; 80(3):181-8. PubMed ID: 11803050
[TBL] [Abstract][Full Text] [Related]
38. Disease-causing SAP mutants are defective in ligand binding and protein folding.
Li C; Iosef C; Jia CY; Gkourasas T; Han VK; Shun-Cheng Li S
Biochemistry; 2003 Dec; 42(50):14885-92. PubMed ID: 14674764
[TBL] [Abstract][Full Text] [Related]
39. Genomic organization and characterization of mouse SAP, the gene that is altered in X-linked lymphoproliferative disease.
Wu C; Sayos J; Wang N; Howie D; Coyle A; Terhorst C
Immunogenetics; 2000 Aug; 51(10):805-15. PubMed ID: 10970095
[TBL] [Abstract][Full Text] [Related]
40. The X-linked lymphoproliferative disease gene product SAP associates with PAK-interacting exchange factor and participates in T cell activation.
Gu C; Tangye SG; Sun X; Luo Y; Lin Z; Wu J
Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14447-52. PubMed ID: 16983070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
